Zell am See Salzburg - Austria - FINAL PROGRAM - Radioactive Isotopes in Molecular Imaging & Therapy - ogn
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Radioactive Isotopes in Molecular Imaging & Therapy
33RD International Austrian Winter Symposium
&
13TH ALPE ADRIA NUCLEAR MEDICINE SYMPOSIUM | JOINT MEETING
Zell am See
Salzburg - Austria
FINAL PROGRAM
24 – 27 January 2018
1
WELCOME
33RD International Austrian Winter Symposium
&
13TH Alpe Adria Nuclear Medicine Symposium
On behalf of the
Austrian Society of Nuclear Medicine & Molecular Imaging (OGNMB)
and the
Faculty of the Alpe Adria Nuclear Medicine Symposium
and the
Congress Committee
we have the pleasure of inviting you to Zell am See, located in the heart of Austria.
This congress is being organized by the Austrian Society of Nuclear Medicine & Molecular Imaging together
with the 13th ALPE ADRIA Nuclear Medicine Symposium. Under the auspices of our international Congress
President Ignasi Carrio, both international and national speakers as well as clinical and preclinical experts from
the fields of Medicine, Radiopharmacy, Physics and Molecular Diagnostics will contribute to a comprehensive
and up-to-date program considering latest developments and scientific contents in the field of nuclear
medicine, molecular Imaging and therapy.
We`d like to invite you to hear and discuss exciting interdisciplinary presentations as well as informative CME
sessions and to meet with friends in an picturesque environment that stimulates your thoughts and creativity.
We are looking forward to meeting you again in Zell am See in January 2018
Peter Lind, Klagenfurt Werner Langsteger, Linz Marcus Hacker, Vienna Ignasi Carrio, Barcelona
Chair Alpe Adria Symposium Program Chair OGNMB President OGNMB International Congress President
Under the Auspices of the European Association of Nuclear Medicine (EANM)
Registration & Hotel booking only ONLINE possible – please visit: www.ogn.at
2
CONGRESS ORGANISATION
Faculty
Ignasi Carrio, Barcelona Amir Kurtaran, Vienna
Thomas Beyer, Vienna Werner Langsteger, Linz
Marcus Hacker, Vienna Markus Mitterhauser, Vienna
Armin Stegmayr, Innsbruck Michael Gabriel, Linz
Peter Lind, Klagenfurt Jean Noel Talbot, Paris
GENERAL INFORMATION
Congress Venue Congress Secretariat
Ferry Porsche CONGRESS CENTER Andreas Felser, Petra Neubauer
Brucker Bundesstrasse 1a – A - 5700 Zell am See Schmalzhofgasse 26, A – 1060 Vienna
+43 6542 474 75 0 +43 6542 474 75 75 +43 1 890 44 27 +43 1 890 44 27 29
email: binderitsch@fpcc.at URL: www.fpcc.at email: info@ogn.at URL: www.ogn.at
WLAN Congress Language
User OGNMB English
Passwort OGNMB2018
Congress Office
Wednesday 24 January 2018 09:00 – 19:00
Thursday 25 January 2018 07:30 – 18:00
Friday 26 January 2018 07:30 – 18:00
Saturday 27 January 2018 07:30 – 12:00
Registration fees (online only) until 15 Nov 2017 on site
Full registration (non - member) € 200 (250) € 280 (330)
Trainees (non - member) € 150 (200) € 230 (280)
Technologists, students (non - member) € 100 (125) € 150 (175)
Single – day ticket € 150
15 European CME Credits
The ‘’Radioactive Isotopes in Molecular Imaging, 33rd International Austrian Winter Symposium”,
January 24 – 27, 2018 is accredited by the European Accreditation Council for Continuing Medical
Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an
institution of the European Union of Medical Specialists (UEMS), www.uems.net
The ‘’Radioactive Isotopes in Molecular Imaging, 33rd International Austrian Winter Symposium” was
granted 15 European CME credits. Through an agreement between the European Union of Medical
Specialists and the American Medical Association, physicians may convert EACCME credits to an
equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME
credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
3
WEDNESDAY 24 January 2018 | MORNING
Pre Congress Symposium
‘’ How To Do ”
How To Do 1 Update in Nuklear Kardiologie (Strahlenreduktion, Gerätetechnologie 10:00 – 12:00
Belastungsagenten, Radiopharmaka)
S Graf Wien & C Pirich Salzburg & G Dobrozemsky Wien
Lunch Break 12:00 – 13:30
How To Do 2 Skelettszintigraphie und SPECT/CT: Durchführung und 13:30 – 15:00
klinische Applikationen
HJ Gallowitsch, Klagenfurt & P Knoll, Wien
Coffee Break 15:00 – 15:30
How To Do 3 NM Therapieverfahren: Indikationsstellung im Setting des 15:30 – 17:00
Tumorboards, Durchführung & NW Management
(SD - Ca, GEP NET Paragangliome, ProstataCa: Ra - 223, Lu - 177 PSMA, SIRT)
M Gabriel, Linz & A Haug Wien
4
WEDNESDAY 24 January 2018 | EVENING
Opening
Welcome 19:00
Werner Langsteger, Linz
Program Chair
Marcus Hacker, Vienna
OGNMB President
Ignasi Carrio, Barcelona
Scientific Chair
Peter Lind, Klagenfurt
Alpe Adria Symposium Chair
Award Presentations
W Wadsak, Vienna 19:20
OGNMB - General Research Award 2017 sponsored by BSM
Ilse Zolle - Award for Basic Sciences in Nuclear Medicine 2017 sponsored by THP
“ The Zell Lecture “
The Criminal Psychological Point of View of Personal Crisis Situations
Krisensituationen und deren psychologische Gesetze
Dr Thomas Müller, Vienna
Austrian Profiler
Welcome Reception
5
THURSDAY 25 January 2018 | MORNING
Session 1 The Scientific Chair Session 08:00 – 09:00
Challenges Ahead for Imaging in Clinical Medicine:
How to Best Position Nuclear Medicine and Molecular Imaging
Chair: I Carrio, Barcelona & W Langsteger, Linz
Oncology 08:00 – 08:20
M Hacker, Vienna
Cardio Vascular 08:20 – 08:40
H Schelbert, Los Angeles
Brain 08:40 – 09:00
T van Eimeren, Cologne
Coffee Break 09:00 – 09:30
Session 2 Image Guided Interventions 09:30 – 11:00
Chair: T Beyer, Vienna & HJ Biersack, Bonn
An Update on SIRT Therapy 09:30– 09:50
S Müller, Essen
Hybrid Imaging for RTP 09:50 – 10:10
E Troost, Dresden
Fluoroscence Imaging - Guided Surgery 10:10 – 10:30
M Brom, Nijmegen
PET/MR Guided Prostate Cancer Biopsies 10:30 – 10:50
M Hartenbach, Vienna
Coffee Break 11:00 – 11:30
Session 3 Oncology | Free Papers 11:30 – 12:30
Chair: M Beheshti, Linz & H Schelbert, Los Angeles
Ultra - Fast Wholebody Oncologic FDG PET/CT: A New Capability Enabled by 11:30 – 11:40
Digital Photon Counting PET/CT Technology
M Knopp, Columbus
The FALCON Trial: Impact of 18F - Fluciclovine PET/CT on Clinical Management 11:40 – 11:50
Choices for Men with Biochemically Recurrent Prostate Cancer
R Frood, Leeds
Bi – 213 – Anti – EGFR - MAb Therapy of Recurrent Bladder Cancer 11:50 – 12:00
K Scheidhauer, Munich
Early PET Imaging of 68Ga - PSMA-11 PET/CT Increases the Detection Rate of 12:00 – 12:10
Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence
C Uprimny, Innsbruck
Gender Specific Analysis of 11C - Methionine PET Examination in Patients 12:10 – 12:20
with Newly Diagnosed Gliomas
S Rasul, Vienna
Assessing Post - Radioembolization Lung Shunt Fraction of Y - 90 Microspheres: 12:20 – 12:30
A Clinical Feasibility Study Using Digital Photon Counting PET/CT
CL Wright, Columbus
6
THURSDAY 25 January 2018 | AFTERNOON
PHILIPS Lunch Symposium (for details see page 24) 12:30 – 14:00
Session 4 What’s Up, Sugar? 14:15 – 15:45
Chair: M Mitterhauser, Vienna & W Wadsak, Vienna
Novel insights into the biochemistry and physiology of carbohydrate metabolism 14:15 – 14:35
A Haschemi, Vienna
FDG Metabolism Paths beyond Hexokinase 14:35 – 14:55
G Sambuceti, Genova
FDG Uptake in Preclinical Cancer Models: Pearls and Pitfall 14:55 – 15:15
E Koziolek, Berlin
Sodium - Coupled Glucose Transporters 15:15 – 15:35
C Scafoglio, Los Angeles
Coffee Break 15:45 – 16:15
Session 5 Early Fireside Quiz – Pitfalls and Artefacts 16:15 – 17:15
ALPE ADRIA vs OGNMB
Moderators: JN Talbot, Paris & T Beyer, Vienna
Team Players| ALPE ADRIA
AT Golubic, Croatia | L Lezaic, Slovenia | P Zucchetta, Italy | S Sorko, Austria
Team Players| OGNMB
M Beheshti, Linz | S Mirzai, Vienna | M Hartenbach, Vienna | C Pirich, Salzburg
Session 6 OGNMB General Assembly | Lecture Hall 17:30 – 19:00
7
FRIDAY 26 January 2018 | MORNING
Session 7 Personalized Dosimetry - Pro | Con 08:00 – 09:00
Chair: C la Fougere, Tübingen & S Ezziddin, Homburg
In Favour 08:00 – 08:30
M Lassmann, Wuerzburg
Against 08:30 – 09:00
A Haug, Vienna
Coffee Break 09:00 – 09:30
Session 8 Controversies in the Management of Hepatic Metastases in NEN 09:30 – 11:00
Chair: M Gabriel, Linz & JN Talbot, Paris
Nuclear Medicine Physicians´ View 09:30 – 09:50
S Ezziddin, Homburg
Endocinologists´ View 09:50 – 10:10
C Auernhammer, Munich
Surgeons´ View 10:10 – 10:30
K Kaczirek, Vienna
Radiologists´ View 10:30 – 10:50
R Bale, Innsbruck
Coffee Break 11:00 – 11:30
Session 9 Radiopharmacy and Physics | Free Papers 11:30 – 12:30
Chair: C Decristoforo, Innsbruck & M Lassmann, Würzburg
Patient Radiation Exposure after Parathyroid Imaging in Nuclear Medicine 11:30 – 11:40
S Rep, Ljubljana
Sex Differences in Blood Pharmacokinetics and Metabolism of 11:40 – 11:50
(S) - [18F]THK5117 and [18F]THK5351 in Rats
S Mairinger, Seibersdorf
High Diagnostic Value of a New Renal Tubular Imaging Agent 11:50 – 12:00
“L – Ethylenedicysteine” in Children Dynamic Scintigraphy
MC Fornito, Catania
Peptides labelling with 64Cu and 68Ga on Heterogeneous Phase using a 12:00 – 12:10
Microfludic System
D Seifert, Rez
PET20.0: Design of a Monolithic Total Body PET with 2.00 mm Spatial Resolution 12:10 – 12:20
and 20 x higher Sensitivity
S Vandenberghe, Ghent
Clinical Validation of EARL - Compliant Reconstruction of Digital Photon 12:20 – 12:30
Counting PET/CT: An Intra-individual Clinical Comparison Study to Conventional
Photomultiplier Tube - based PET/CT
K Binzel, Ohio
BAYER Lunch Symposium (for details see page 24) 12:30 – 13:30
8FRIDAY 25 January 2018 | AFTERNOON
OGNMB Award Ceremony 13:30 - 14:15
Chairs: W Wadsak & M Hacker
Awarding of Honorary Membership of the OGNMB to emer Prof Dr Rudolf Höfer
Laudatio & Film Presentation
M Hacker & T Beyer
Session 10 ALPE ADRIA JOINT SESSION
Prostate Cancer – Diagnostic and Therapeutic Strategies
in Nuclear Medicine 14:15 – 15:15
Chair: D Huic, Zagreb & P Lind, Klagenfurt
Is Bone Scintigraphy still Valuable in Prostate Cancer ? Benefit of SPECT - CT ? 14:15 – 14:30
L Ležaić, Ljubljana
Different PET – Tracers in Prostate Cancer: F18 Choline, Ga - 68 PSMA,
Tc - 99 PSMA – Indications and Results 14:30 – 14:45
AT Golubic, Zagreb
Ra - 223 (Xofigo®) Therapy: Indications, Therapy Monitoring and
Institutional Results 14:45 – 15:00
S Sorko, Klagenfurt
Utility of 18F - Choline MR - PET in Prostate Cancer Patients 15:00 – 15:15
P Zucchetta, Padua
Coffee Break 15:15 – 15:45
Session 11 Inflammation Imaging 15:45 – 16:45
Chair: M Hacker, Vienna & I Carrio, Barcelona
Oncological Diseases 15:45 – 16:05
F Galli, Rome
Neuropsychiatric Diseases 16:05 – 16:25
C la Fougere, Tübingen
Cardiovascular Diseases 16:25 – 16:45
F Bengel, Hannover
Coffee Break 16:45 – 17:00
Session 12 Distinguished Pioneers Lecture 17:00 – 18:00
Laudatio
T Beyer, Vienna
45 Years of Nuclear Medicine 1973 – 2018: A To - Do List for Young Scientists
HJ Biersack, Bonn
9SATURDAY 27 January 2018 | MORNING
Session 13
POSTER WALK 1 08:00 – 09:00
Chair: T Traub - Weidinger, Vienna & E v Guggenberg, Innsbruck
Relationship of Dual Time Point Myocardial SPECT - CT with Peak Creatine Kinase and Cardiac Troponin I
Levels
C Farhan, Vienna
Visualization of Abcg2 Transport Activity in the Liver with [11C] Erlotinib and Positron Emission
Tomography
A Traxl, Seibersdorf
Lenvatinib - Therapy for Patients with Radioiodine - Refractory Differentiated Thyroid Cancer – Our
Experiences with Lenvima®
S Sorko, Klagenfurt
The Influence of Attenuation Correction and Acquisition Time on the SPECT Image Quality
S Šuštar, Ljubljana
89Zr - Siderophore - Affibody Conjugates for Imaging EGFR Expression
C Decristoforo, Innsbruck
Assessment of Renal Scars and Differential Renal Function (DRF) in Children with Ureteral Reflux: Tc
99m L - Ethylenedicysteine Dynamic Scan vs Tc 99m DMSA Static Scan
MC Fornito, Catania
Interdisciplinary Preoperative Management of Thyroid Patients and Thyroid Cancer Incidence
M Kudlacek, Vienna
18F - FDG PET/CT in the Detection of an Early Infection of Arteriovenous Grafts in Hemodialysis Patients
P Koranda, Olomouc
POSTER WALK 2 08:00 – 09:00
Chair: R Aigner, Graz & T Mindt, Vienna
Role of 18F - FDG PET in Differentiation of Portal Malignant Thrombus from Bland Thrombus in Patient
with Hepatocellular Carcinoma (HCC): Case Report
MC Fornito, Catania
Optimization of High Definition Digital PET/CT Reconstruction for Neurologic Imaging
K Binzel, Columbus
Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA – Radio – Ligand -
Therapy - An Empiric Proof of Concept for the Future
RP Baum, T Langbein, Bad Berka
A New Program for the Optimisation of Mo99 - Tc99m Generator Selection
WH Thomson, Birmingham
Ultrasound Criteria for Risk Stratification of Thyroid Nodules in the Previously Iodine Deficient Area of
Austria. A single Centre, Retrospective Analysis
V Petz, Vienna
Evaluation of Cerebral P - Glycoprotein Function in an Alzheimer’s Disease Mouse Model with Positron
Emission Tomography
V Zoufal, Seibersdorf
The Curious Fever: The Diagnostic Value of 18F - FDG in FUO in a Large Single - Center Retrospective
Study on 300 Patients
F Weitzer, Graz
TAFC Modifications
C Decristoforo, Innsbruck
10SATURDAY 27 January 2018 | MORNING
Session 14 ALPE ADRIA JOINT SESSION
Ablative Concepts in Graves Diseases 09:00 – 10:30
Chair: S Gaberscek, Ljubljana & O Geatti, Udine
Pro Surgery 09:00 – 09:20
R Mittermair, Klagenfurt
Pro Radioiodine Ablation 09:20 – 09:40
T Jukić, Zagreb
Radioiodine Ablation in Graves´ Disease vs Long - time Thyreostatic Drugs 09:40 – 10:00
L Cuppari, Padua
Treatment of Graves´ Orbitopathy 10:00 – 10:20
P Jaki Mekjavić, Ljubljana
Coffee Break 10:30 – 11:00
Session 15 Updates in Nuclear Medicine Instrumentation 11:00 – 12:30
Chair: B Gruy, Linz & T Beyer, Vienna
Digital PET 11:00 – 11:20
P Maniawski, Philips
Quantitative SPECT 11:20 – 11:40
H Vija, Siemens
CZT Detektor (Cadmium, Zink, Tellur) 11:40 – 12:00
Eli Stern, GE
Roundtable: Where do we go from here 12:00 – 12:30
Moderation: T Beyer, Vienna & B Gruy, Linz & M Hacker, Vienna
CLOSING 12:30 – 12:45
FAREWELL
MEETING INFORMATION CONGRESS
Wednesday | 24 January 2018
08:00 – 11:00 Blue Box 1 + 2 Facharztprüfung
16:30 – 18:30 Blue Box 1 + 2 OGNMB Beirat
Thursday | 25 January 2018
11:30 – 12:30 White Box Ausschuss Medizinphysik und Strahlenschutz
17:30 – 19:00 Lecture Hall OGNMB Generalversammlung
Friday | 26 January 2018
11:30 – 12:30 White Box Ausschuss Nuklearmedizinische Therapie
12:30 – 13:30 White Box Ausschuss Hybridbildgebung
13:30 – 14:15 White Box Ausschuss Schilddrüse
15:00 – 16:00 White Box Ausschuss Radiopharmaka
11FRIDAY 26 January 2018 | MORNING
Radiotechnologie - Symposium 2018
Wissenschaftliches Programm | Medizinisch Technischer Zweigverein der OGNMB
Organisation: K Artner, Wien I S Gattringer, Bad Dürnberg I Ch Harris-Castellitz Wien I Stegmayr A Innsbruck
Registrierung und offizielle Eröffnung 08:00 – 08:30
Session 1 08:30 – 10:00
Vorsitz: A Stegmayr, Innsbruck
Entwicklungen in der molekularen Bildgebung: was sehen wir wirklich? 08:30 – 09:00
M Zeilinger, Wiener Neustadt
„Kontrast der Wissen schafft “ Radiologietechnologie & Forschung 09:00 – 09:30
F Pichler, Wiener Neustadt / Wien
Röntgenkontrastmittel - Geschichte, Grundlagen und Anwendung 09:30 – 10:00
D Sideris, Wien
Pause 10:00 – 10:15
Session 2 10:15 – 11:15
Vorsitz: A Stegmayr, Innsbruck
Qualitätsmanagement im Krankenhaus 10:15 – 10:45
M Firmötz, Linz
Tl - Szintigraphie des Herzen 10:45 – 11:15
A Gabriel - Werkl, Villach
Generalversammlung des MTZV der OGNMB 11:15 – 11:45
Pause 11:45 – 12:15
Besuch des OGNMB Kongresses 12:15 – 17:00
(for more details see page 24)
12SATURDAY 27 January 2018 | MORNING
Radiotechnologie - Symposium 2018
Wissenschaftliches Programm | Medizinisch Technischer Zweigverein der OGNMB
Organisation: K Artner, Wien I S Gattringer, Bad Dürnberg I Ch Harris-Castellitz Wien I Stegmayr A Innsbruck
Registrierung 08:00 – 08:30
Session 3 08:30 – 10:00
Vorsitz: Ch Harris - Castellitz, Wien
Radiation Exposure in Parathyroid Imaging 08:30 – 09:00
S Rep, Ljubljana
Image Quality Aspects of Attenuation Correction and Acquisition Time
in Single Photon Emission Computer Tomography 09:00 – 09:30
S Suster, Ljubljana
Strahlenschutz und – belastung in der Therapie und Diagnostik 09:30 – 10:00
J Preitfellner, Wien
Pause 10:00 – 10:15
Session 4 10:15 – 11:15
Vorsitz: K Artner, Wien
Myokard - Perfusions - Szintigraphie mittels Gated – SPECT
Kann die Ruhe - LVEF durch eine Spätaufnahme ohne zusätzliche
Tracerapplikation ersetzt werden? 10:15 – 10:45
M Enderle, Feldkirch / Innsbruck
Evaluierung der Ermittlung des T - Score der Lendenwirbelsäule aus der
Ganzkörper – DXA – Messung und Darstellung der daraus resultierenden
Patientendosis – Einsparung 10:45 – 11:15
A Stegmayr, Innsbruck
FB - Verpflichtung und Registrierung 11:15 – 11:45
P Scherer, Salzburg, M Weissensteiner, Wien
Preisverleihung THP - Preis und Schlusswort 11:45 – 12:15
(for more details see page 24)
13ANNOUNCEMENT 2019
13TH OGNMB CONGRESS 2019
Ferry Porsche Congress Center
Zell am See
Salzburg
ANNOUNCEMENT
23 – 25 January 2019
14MAP – ZELL AM SEE
15MAP – FERRY PORSCHE CONGRESS CENTER
Radioactive Isotopes in Molecular Imaging
33rd International Austrian Winter Symposium
January 24 – 27, 2018
Spectrum & THP Bayer Sanofi DSD
Scannwork 6x3 3,5 x 2 4x2 2,5 x 2
Elimpex Ipsen ITM Shire
2x2 2x2 2x2 2x2
Topmed
Philips Hermes
Rotop
6x2,5 3x2
CATERING
MiE AAA IASON
CATERING 3x2 3x2 3x2
RadioMedic
tomics
Scin-
2x2
BSM Seibers- Siemens
6x3 dorf
2x2
5x3 Eisai ABX Sandoz GE Mediso
2x2
3x2 3x2 3x2
16EXHIBITORS & SPONSORS 2018
AAA Germany GmbH MiE medical imaging electronics GmbH
D – 53121 Bonn, Saime-Genc-Ring D - 23845 Seth, Hauptstrasse 112
ABX advanced biochemical compounds – Philips GmbH
Biomedizinische Forschungsreagenzien GmbH A - 1120 Vienna, Euro Plaz Kranichberggasse 4
D – 1454 Radeberg, H.-Glaeser Str. 10-14
AIPES RadioMedic ltd.
B – 1050 Brussels, Avenue Louise 65 – Box 5 – Floor 4 CZ – 25068 Rez by Prague, Husinec-Rez 289
Bayer Austria GesmbH ROTOP Pharmaka GmbH
A - 1160 Vienna, Herbststrasse 6 – 10 D – 01328 Dresden, Bautzner Landstr. 400
BSM - Diagnostica GmbH SANDOZ GmbH
A - 1080 Wien, Alserstrasse 25 A - 1020 Vienna, Stella-Klein-Loew-Weg 17
DSD Pharma GmbH Sanofi-aventis GmbH – Genzyme
A - 3002 Purkersdorf, Wiener Strasse 12/4 A - 1220 Vienna, Leonard-Bernstein-Strasse 10
Eisai GesmbH Scannworks medical imaging GmbH
A - 1220 Vienna, Leonard-Bernstein-Strasse 10 A – 3910 Zwettl, Mittelweg 4a
Elimpex - Medizintechnik GmbH Scintomics GmbH
A - 2340 Moedling, Spechtgasse 32 D - 82256 Fürstenfeldbruck, Lindach 4
GE Healthcare Seibersdorf Labor GmbH
A - 1120 Vienna, Technologiestrasse 10 A - 2444 Seibersdorf
HERMES Medical Solutions AB Shire Austria GmbH
UK – WC2E 9LY London, 22 Long Acre A – 1221 Vienna, Industriestrasse 67
IASON GmbH Siemens Healthcare Diagnostic GmbH
A - 8054 Graz - Seiersberg, Feldkirchnerstrasse 4 A - 1210 Wien, Siemensstrasse 90
Ipsen Pharma GmbH Spectrum Dynamics Medical SA
D – 76275 Ettlingen, Willy Brandt Str. 3 CH- 1110 Morges, Rue de Lausanne 31
ITM Isotopen Technologien München AG THP Medical Products Vertriebs GmbH
D – 85748 Garching near Munich, Lichtenbergstrasse 1 A - 1210 Vienna, Shuttleworthstrasse 19
Mediso GmbH TopMed Trade e.U.
D - 48149 Muenster, Steinfurter Strasse A - 8010 Graz, Hollerbergweg 7
17EXHIBITORS & SPONSORS 2018
AAA Germany GmbH
ABX advanced biochemical compounds –
Biomedizinische Forschungsreagenzien GmbH
AIPES
Bayer Austria GesmbH
BSM – Diagnostica GmbH
DSD Pharma GmbH
Eisai GesmbH
Elimpex Medizintechnik GmbH
GE Healthcare
HERMES Medical Solutions
IASON GmbH
Ipsen Pharma GmbH
ITM Isotopen Technologien München AG
Mediso GmbH
MiE medical imaging electronics GmbH
Philips Austria GmbH
RadioMedic ltd.
ROTOP Pharmaka GmbH
SANDOZ GmbH
Sanofi-aventis GmbH – Genzyme
Scannworks medical imaging GmbH
Scintomics GmbH
Seibersdorf Labor GmbH
Shire Austria GmbH
Siemens Healthcare Diagnostic GmbH
Spectrum Dynamics Medical SA
THP Medical Products Vertrieb GmbH
TopMed Trade e.U.
18CORPORATE MEMBERS
The OGNMB gratefully acknowledges its supporting corporate members
19SPEAKERS & CHAIRS
R Aigner HJ Gallowitsch
Department of Radiology, Division of Nuclear Medicine, Medical Department of Nuclear Medicine, Klinikum Klagenfurt am Wörthersee,
University of Graz, Auenbruggerplatz 9, A – 8036 Graz, Austria Feschnigstrasse 11, A – 9020 Klagenfurt am Wörthersee, Austria
C Auernhammer O Geatti
Medizinische Klinik IV, Campus Grosshadern, Endokrinologie, Medicina Nucleare, S.M.M., University Hospital, P.zza S. Maria della
Ludwig – Maximilians – Universität, Marchioninistrasse 15, Misericordia 15, I – 33100 Udine, Italy
D – 81377 Munich, Germany
AT Golubic
R Bale
Department of Nuclear Medicine and Radiation Protection, University
Department of Radiology, University of Innsbruck, Anichstrasse 35,
Hospital Centre Zagreb, Kišpatićeva 12, HR – 10000 Zagreb, Croatia
A - 6020 Innsbruck, Austria
S Graf
RP Baum
Klinik für Molekulare Radiotherapie, Zentralklinik Bad Berka, Abteilung für Kardiologie, Universitätsklinik für Innere Medizin II,
Robert - Koch - Allee 9, D – 99437 Bad Berka Medical University of Vienna, Waehringer Guertel 18 – 20, A – 1090
Vienna, Austria
M Beheshti
PET – CT Center Linz, Nuclear Medicine & Endocrinology, St Vincent’s B Gruy
Hospital Linz, Seilerstaette 4, A – 4010 Linz, Austria PET – CT Center Linz, Nuclear Medicine & Endocrinology, St Vincent’s
Hospital Linz, Seilerstaette 4, A – 4010 Linz, Austria
F Bengel
Medical University Hannover, Carl - Neuberg - Strasse 1, D – 30625 E von Guggenberg
Hannover, Germany Department of Nuclear Medicine, University of Innsbruck,
T Beyer Anichstrasse 35, A - 6020 Innsbruck, Austria
Center of Medical Physics and Biomedical Engineering, M Hacker
Medical University of Vienna, General Hospital Vienna, Department of Biomedical Imaging and Image - guided Therapy,
Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria Division of Nuclear Medicine, Medical University of Vienna,
HJ Biersack Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria
Emeritus, Klinik und Poliklinik für Nuklearmedizin, Friedrich - Wilhelms M Hartenbach
- Universität Bonn, Sigmund – Freud - Strasse 25, D – 53127 Bonn – Department of Biomedical Imaging and Image - guided Therapy,
Venusberg, Germany Division of Nuclear Medicine, Medical University of Vienna,
K Binzel Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria
Wright Center of Innovation, The Ohio State University, 410 W 10th A Haschemi
Ave, Columbus, OH 43210, USA Department of Biomedical Imaging and Image - guided Therapy,
M Brom Division of Nuclear Medicine, Medical University of Vienna,
Dept. of Nuclear Medicine, Radboud University Nijmegen Medical Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria
Centre, Geert Grootplein 8, NL – 6525 GA Nijmegen, Netherlands A Haug
I Carrio Department of Biomedical Imaging and Image - guided Therapy,
Nuclear Medicine Unit, Hospital de la Santa Creu Sant Pau, Division of Nuclear Medicine, Medical University of Vienna,
Sant Antoni M Claret 167, E – 08025 Barcelona, Spain Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria
L Cuppari D Huic
Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Centre for Radiation Medicine & Protection, University Hospital
Oncology IOV – IRCCS, via Gattamelata 64, I – 35128 Padova, Italy Centre Zagreb – Rebrok, Kispaticeva 12, HR – 10000 Zagreb, Croatia
C Descristoforo P Jaki Mekjavic
Department of Nuclear Medicine, University of Innsbruck,
Medical Faculty, University of Ljubljana, Vrazov trg 2, SL – 1000
Anichstrasse 35, A - 6020 Innsbruck, Austria
Ljubljana, Slovenia
S Ezziddin
T Jukic
Department of Nuclear Medicine, Saarland University Hospital,
Kirrberger Strasse, Gebäude 50, D – 66421 Homburg / Saar, Germany Centre for Radiation Medicine & Protection, University Hospital
Centre Zagreb – Rebrok, Kispaticeva 12, HR – 10000 Zagreb, Croatia
C Farhan
Department of Nuclear Medicine with PET-Center, K Kaczirek
Wilhelminenhospital, Montleartstraße 37, A - 1160 Vienna - Austria Klinische Abteilung für Allgemeinchirurgie, Medical University of
MC Fornito Vienna, Waehringer Guertel 18 - 20, A – 1090 Vienna, Austria
Nuclear Medicine Department, A.R.N.A.S, Garibaldi Via Palermo 636, I P Knoll
Institut für Nuklearmedizin mit PET – CT Zentrum, Wilhelminenspital,
– Catania, Italy
Montleartstrasse 37, A – 1171 Wien, Austria
R Frood
M Knopp
Nuclear Medicine Department, St James' University Hospital, 1st Floor
Bexley Wing, Beckett Street, UK - LS9 7TF Leeds, UK Wright Center of Innovation, The Ohio State University, 410 W 10th
Ave, Columbus, OH 43210, USA
S Gaberscek
Department of Nuclear Medicine, University Medical Centre Ljubljana, P Koranda
Zaloska 7, SL - 1525 Ljubljana, Slovenia Department of Nuclear Medicine, University Hospital Olomouc and
M Gabriel Palacký University, Křížkovského 511/8, 771 47 Olomouc - Czech
Department of Nuclear Medicine & Endocrinology, Kepler University, Republic
Krankenhausstrasse 9, A – 4021 Linz, Austria M Kudlacek
F Galli Institute of Nuclear Medicine with PET-Center, Wilhelminenspital,
Nuclear Medicine Unit, Faculty of Medicine and Psychology, Vienna, Montleartstraße 37, A - 1160 Vienna - Austria
Department of Medical - Surgical Sciences and Translational Medicine,
"Sapienza" University, Ospedale S. Andrea, Via di Grottarossa 1035, I –
00189, Rome, Italy
20SPEAKERS & CHAIRS
E Koziolek K Scheidhauer
BERIC - Berlin Experimental Radionuclide Imaging Center, Nuclear Medicine Clinic & Polyclinic, Klinikum rechts der Isaar,
Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, Technical University, Ismaninger Strasse 22, D – 81675 Munich,
D - 13353 Berlin, Germany Germany
A Kurtaran H Schelbert
Institut für Nuklearmedizin, Krankenanstalt Rudolfstiftung, Juchgasse JNM Office, SNM
25, A – 1030 Vienna, Austria 1850 Samuel Morse Drive, Reston, VA 20190 – 5316, USA
C la Fougère D Seifert
Department of Nuclear Medicine and Clinical Molecular Imaging, Nuclear Physics Institute of the CAS, Rez 130, 250 68 Rez, Czech
Department of Radiology, University Hospital Tuebingen, Republic
Otfried - Mueller Strasse 14, D – 72076 Tuebingen, Germany
S Sorko
W Langsteger
Department of Nuclear Medicine, Klinikum Klagenfurt am Wörthersee,
PET – CT Center Linz, Nuclear Medicine & Endocrinology, St Vincent’s
Feschnigstrasse 11, A – 9020 Klagenfurt am Wörthersee, Austria
Hospital Linz, Seilerstaette 4, A – 4010 Linz, Austria
E Stern
M Lassmann
GE Healthcare, 4 Hayozma st, 3903204 Tirat Hacarmel, Israel
Department of Nuclear Medicine, University Hospital Wuerzburg,
Oberduerrbacher Strasse 6, D – 97080 Wuerzburg, Germany S Sustar
L Ležaić Departments of Nuclear Medicine, University Medical
Department for Nuclear Medicine, University Medical Centre Ljubljana, Centre Ljubljana, Zaloška cesta 7, 1000 Ljubljana, Slovenia
Zaloska 7, SL – 1525 Ljubljana, Slovenia JN Talbot
P Lind Hôpital Tenon, Med. Nuc., 4 rue de Chine, F – 75020 Paris, France
Department of Nuclear Medicine, Klinikum Klagenfurt am Wörthersee, WH Thomson
Feschnigstrasse 11, A – 9020 Klagenfurt am Wörthersee, Austria Physics and Nuclear Medicine, City Hospital, Dudley Road, West
S Mairinger Midland, UK - B18 7QH Birmingham, United Kingdom
AIT – Austrian Institute of Technology, 2444 Seibersdorf, Donau – City A Traxl
Strasse 1, A – 1220 Vienna, Austria AIT – Austrian Institute of Technology, 2444 Seibersdorf, Donau – City
P Maniawski Strasse 1, A – 1220 Vienna, Austria
Advanced Molecular Imaging & CT Oncology, Philips Healthcare, USA E Troost
T Mindt Department of Radiotherapy and Radiation Oncology, Carl Gustav
Department of Biomedical Imaging and Image - guided Therapy, Carus University, Fetscherstrasse 74, D – 01307 Dresden, Germany
Division of Nuclear Medicine, Medical University of Vienna, T Traub – Weidinger
Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria Department of Biomedical Imaging and Image - guided Therapy,
S Mirzaei Division of Nuclear Medicine, Medical University of Vienna,
Department of Nuclear Medicine and PET – CT Center, Wilhelminen Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria
Hospital, Montleartstrasse 37, A – 1171 Vienna, Austria C Uprimny
M Mitterhauser Department of Nuclear Medicine, University of Innsbruck, Anichstrasse
Department of Biomedical Imaging and Image - guided Therapy, 35, A - 6020 Innsbruck, Austria
Division of Nuclear Medicine, Radiochemistry and Biomarker T van Eimeren
Development Unit, Medical University of Vienna, Klinik und Poliklinik für Nuklearmedizin, Kerpener Strasse 62, D - 50937
Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria Cologne, Germany
R Mittermair S Vandenberghe
Abt. für Allgemein- und Viszeralchirurgie, Klinikum Klagenfurt am Medisip Elis - Ibitech, University Gent, De Pintellaan 185 blok B 5th
Wörthersee, Feschnigstrasse 11, A – 9020 Klagenfurt, Austria floor, B - 9000 Ghent, Belgium
V Petz H Vija
Schilddruesenpraxis Josefstadt, Laudongasse 12, 1080 Vienna, Austria Siemens Medical Solutions USA, Inc., 2501 North Barrington Road,
C Pirich Hoffman Estates, IL 60192 - 2061, USA
Nuclear Medicine & Endocrinology, SALK Paracelsus Medical W Wadsak
University, Muellner Hauptstrasse 48, A – 5020 Salzburg, Austria Department of Biomedical Imaging and Image - guided Therapy,
S Rasul Division of Nuclear Medicine, Radiochemistry and Biomarker
Department of Biomedical Imaging and Image - guided Therapy, Development Unit, Medical University of Vienna,
Division of Nuclear Medicine, Radiochemistry and Biomarker Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria
Development Unit, Medical University of Vienna, F Weitzer
Waehringer Guertel 18 – 20, A – 1090 Vienna, Austria Abteilung für Nuklearmedizin, Univ. Klinik für Radiologie, LKH Graz,
S Rep Auenbruggerplatz 9A, A - 8036 Graz, Austria
Nuclear Medicine Clinic, University Medical Centre Ljubljana, Zaloška CL Wright
cesta 7, SL - 1000 Ljubljana, Slovenia Wright Center of Innovation, The Ohio State University, 410 W 10th
G Sambuceti Ave, Columbus, OH 43210, USA
Nuclear Medicine, IRCCS Policlinico San Martino, University of Genoa, V Zoufal
Viale Pastore 1 I – 16132 Genova, Italy AIT – Austrian Institute of Technology, 2444 Seibersdorf, Donau – City
C Scafoglio Strasse 1, A – 1220 Vienna, Austria
Division of Pulmonary and Critical Care Medicine, David Geffen School P Zucchetta
of Medicine, UCLA Medical Center, 10833 Le Contre Ave, Los Angeles, Ed. Giustinianeo, Servizio di Medicina Nucleare, Via Giustinian, I -
CA – 90095, USA 35128 Padova, Italy
21INFORMATION LUNCH SYMPOSIUM INDUSTRY
THURSDAY 25 January 2018 | AFTERNOON
Lunch Symposium PHILIPS 12:30 – 14:00
Vereos with Digital Photon Counting, Setting New Standards in Speed, Precision and Dose to Advance Clinical PET
Three years’ Experience at the Ohio State University
MV Knopp, USA
Initial Experience in Europe
P Maniawski, USA
INFORMATION LUNCH SYMPOSIUM INDUSTRY
FRIDAY 26 January 2018 | AFTERNOON
Lunch Symposium BAYER 12:30 – 13:30
The Significance of Radium – 223 in the Therapy Landscape of Advanced Prostate Cancer
Chair: M Hacker, Vienna
Nuclear Medicine
A Haug, Vienna
Urology
J Bektic, Innsbruck
INFORMATION RADIOTECHNOLOGIE – SYMPOSIUM
FRIDAY 26 January 2018 | SATURDAY 27 January 2018
Mit der freundlichen Unterstützung folgender Firmen
22ANNOUNCEMENT 2020
Radioactive Isotopes in Molecular Imaging &
Therapy
34TH International Austrian Winter Symposium
Ferry Porsche Congress Center
Zell am See
Salzburg - Austria
ANNOUNCEMENT
22 – 25 January 2020
23NOTES 24
NOTES 25
You can also read
